Evidence map›Paper›PMID 38130941›Full record

ArticleFrontiers in pediatrics2023

Butyrate suppresses experimental necrotizing enterocolitis-induced brain injury in mice.

Maribel Martinez, Wei Yu, Heather L Menden, Tianhua Lei, Paula Monaghan-Nichols, Venkatesh Sampath

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Maribel Martinez *Division of Neonatology, Department of Pediatrics, Children's Mercy Kansas City, Kansas, MO, United States.
Wei Yu *Division of Neonatology, Department of Pediatrics, Children's Mercy Kansas City, Kansas, MO, United States.
Heather L MendenDivision of Neonatology, Department of Pediatrics, Children's Mercy Kansas City, Kansas, MO, United States.
Tianhua LeiDepartment of Biomedical Sciences, University of Missouri Kansas City School of Medicine, Kansas, MO, United States.
Paula Monaghan-NicholsDepartment of Biomedical Sciences, University of Missouri Kansas City School of Medicine, Kansas, MO, United States.
Venkatesh SampathDivision of Neonatology, Department of Pediatrics, Children's Mercy Kansas City, Kansas, MO, United States.
Children's Mercy Hospital · USMercy Research · USUniversity of Missouri–Kansas City · US

Funding

A Safer Glucocorticoid to Treat Neonatal Lung Injury with Limited Adverse Neurologic EffectsR01HD104215 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEFRANCO, DONALD B, MONAGHAN-NICHOLS, A PAULA · 2021 to 2025
$2.9M
Single Immunoglobulin Interleukin-1 Related Receptor and necrotizing enterocolitis in premature infantsR01DK117296 · NIDDK · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI SAMPATH, VENKATESH, UMAR, SHAHID · 2018 to 2022
$2.6M
Selective Glucocorticoid Action in the Developing BrainR01HD087288 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEFRANCO, DONALD B, MONAGHAN-NICHOLS, A PAULA · 2017 to 2021
$2.3M
NICHD NIH HHS R01 HD087288NICHD NIH HHS R01 HD104215NIDDK NIH HHS R01 DK117296
6 · The paper itself

Abstract

Background: Necrotizing enterocolitis (NEC) is a devastating disease in premature infants, and 50% of infants with surgical NEC develop neurodevelopmental defects. The mechanisms by which NEC-induced cytokine release and activation of inflammatory cells in the brain mediate neuronal injury, and whether enteral immunotherapy attenuates NEC-associated brain injury remain understudied. Based on our prior work, which demonstrated that experimental NEC-like intestinal injury is attenuated by the short-chain fatty acid, butyrate, in this study, we hypothesize that NEC-induced brain injury would be suppressed by enteral butyrate supplementation. Methods: A standardized NEC mouse model [enteral formula feeding, lipopolysaccharide (LPS), and hypoxia] was used. Mice were randomized into the following groups: control, NEC, butyrate pretreated NEC, and butyrate control. NEC scoring (1-4 with 4 representing severe injury) was performed on ileal sections using a validated scoring system. Intestinal and brain lysates were used to assess inflammation, proinflammatory signaling, and apoptosis. Results: NEC-induced intestinal injury was attenuated by butyrate supplementation. NEC-induced microglial activation in the cerebral cortex and hippocampus was suppressed with butyrate. NEC increased the number of activated microglial cells but decreased the number of oligodendrocytes. Butyrate pretreatment attenuated these changes. Increased activation of proinflammatory Toll-like receptor signaling, cytokine expression, and induction of GFAP and IBA1 in the cerebral cortex observed with NEC was suppressed with butyrate. Conclusion: Experimental NEC induced inflammation and activation of microglia in several regions of the brain, most prominently in the cortex. NEC-induced neuroinflammation was suppressed with butyrate pretreatment. The addition of short-chain fatty acids to diet may be used to attenuate NEC-induced intestinal injury and neuroinflammation in preterm infants.

Indexed as

brain injurybutyrateinflammationmicrogliaNEColigodendrocyte

Identifiers

PMID38130941
PMCPMC10733464
OpenAlexW4389435624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.